• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
A analysis on the effects of a probiotic mixture on asthma exacerbation frequency in schoolchildren.一项关于益生菌混合物对学龄儿童哮喘发作频率影响的分析。
ERJ Open Res. 2022 May 9;8(2). doi: 10.1183/23120541.00020-2022. eCollection 2022 Apr.
2
Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial.特利鲁单抗治疗重症未控制哮喘患者的疗效和安全性：一项随机、双盲、安慰剂对照、2b 期临床试验。
Lancet Respir Med. 2015 Sep;3(9):692-701. doi: 10.1016/S2213-2600(15)00197-6. Epub 2015 Jul 28.
3
Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study.按需增加布地奈德-福莫特罗使用 1 天对轻度哮喘患者短期发生重度加重风险的影响：SYGMA 1 研究的事后分析。
Lancet Respir Med. 2021 Feb;9(2):149-158. doi: 10.1016/S2213-2600(20)30416-1. Epub 2020 Oct 1.
4
Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials.固定剂量皮下注射瑞利珠单抗对重度未控制哮喘患者哮喘恶化的影响和对口服糖皮质激素依赖哮喘患者糖皮质激素节省作用的影响：两项 3 期、随机、双盲、安慰剂对照试验的结果。
Lancet Respir Med. 2020 May;8(5):461-474. doi: 10.1016/S2213-2600(19)30372-8. Epub 2020 Feb 14.
5
Nocturnal temperature-controlled laminar airflow device for adults with severe allergic asthma: the LASER RCT.成人严重变应性哮喘的夜间温度控制层流装置：LASER RCT。
Health Technol Assess. 2019 Jun;23(29):1-140. doi: 10.3310/hta23290.
6
The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with LS01 (DSM 22775) and B632 (DSM 24706).初级保健环境中儿科哮喘管理中的益生菌（PROPAM）研究：一项使用 LS01（DSM 22775）和 B632（DSM 24706）的随机、对照、双盲试验。
J Immunol Res. 2022 Jan 17;2022:3837418. doi: 10.1155/2022/3837418. eCollection 2022.
7
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis.基线呼出气一氧化氮（FeNO）作为 LIBERTY ASTHMA QUEST 研究中接受安慰剂治疗的未控制的中重度哮喘患者随后发生严重哮喘加重的预后生物标志物：一项事后分析。
Lancet Respir Med. 2021 Oct;9(10):1165-1173. doi: 10.1016/S2213-2600(21)00124-7. Epub 2021 Jun 25.
8
Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.美泊利珠单抗治疗嗜酸粒细胞性哮喘的疗效分层：基于基线嗜酸粒细胞阈值的 DREAM 和 MENSA 研究的二次分析。
Lancet Respir Med. 2016 Jul;4(7):549-556. doi: 10.1016/S2213-2600(16)30031-5. Epub 2016 May 10.
9
Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial.阿奇霉素对持续性未控制哮喘成人哮喘加重和生活质量的影响（AMAZES）：一项随机、双盲、安慰剂对照试验。
Lancet. 2017 Aug 12;390(10095):659-668. doi: 10.1016/S0140-6736(17)31281-3. Epub 2017 Jul 4.
10
Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study.特泽佩umab可减少重度未控制哮喘患者全年的病情加重：PATHWAY 2b期研究的事后分析
J Asthma Allergy. 2021 Jan 11;14:1-11. doi: 10.2147/JAA.S286036. eCollection 2021.

引用本文的文献

1
Effects of probiotics, prebiotics, synbiotics and postbiotics on pediatric asthma: a systematic review.益生菌、益生元、合生元和后生元对小儿哮喘的影响：一项系统评价
Front Nutr. 2025 Apr 25;12:1586129. doi: 10.3389/fnut.2025.1586129. eCollection 2025.
2
The Influence of the Gut Microbiota on Host Health: A Focus on the Gut-Lung Axis and Therapeutic Approaches.肠道微生物群对宿主健康的影响：聚焦肠-肺轴及治疗方法
Life (Basel). 2024 Oct 9;14(10):1279. doi: 10.3390/life14101279.
3
The Microbiota in Children and Adolescents with Asthma.患有哮喘的儿童和青少年的微生物群
Children (Basel). 2024 Sep 27;11(10):1175. doi: 10.3390/children11101175.
4
Distinguishing science from pseudoscience in commercial respiratory interventions: an evidence-based guide for health and exercise professionals.区分商业呼吸干预措施中的科学与伪科学：健康和运动专业人员的循证指南。
Eur J Appl Physiol. 2023 Aug;123(8):1599-1625. doi: 10.1007/s00421-023-05166-8. Epub 2023 Mar 14.
5
Probiotics in Children with Asthma.哮喘儿童中的益生菌
Children (Basel). 2022 Jun 29;9(7):978. doi: 10.3390/children9070978.

本文引用的文献

1
The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with LS01 (DSM 22775) and B632 (DSM 24706).初级保健环境中儿科哮喘管理中的益生菌（PROPAM）研究：一项使用 LS01（DSM 22775）和 B632（DSM 24706）的随机、对照、双盲试验。
J Immunol Res. 2022 Jan 17;2022:3837418. doi: 10.1155/2022/3837418. eCollection 2022.
2
Childhood asthma: pathogenesis and phenotypes.儿童哮喘：发病机制与表型
Eur Respir J. 2022 Jun 9;59(6). doi: 10.1183/13993003.00731-2021. Print 2022 Jun.
3
Novel Insights into the Role of Probiotics in Respiratory Infections, Allergies, Cancer, and Neurological Abnormalities.益生菌在呼吸道感染、过敏、癌症和神经异常中的作用的新见解。
Diseases. 2021 Sep 2;9(3):60. doi: 10.3390/diseases9030060.
4
"Reactance inversion" at low frequencies during lung function measurement by impulse oscillometry in children with persistent asthma.在持续性哮喘儿童中，通过脉冲振荡法进行肺功能测量时，低频下的“电抗反转”
J Asthma. 2022 Aug;59(8):1597-1603. doi: 10.1080/02770903.2021.1955376. Epub 2021 Aug 6.
5
Prevention and Treatment of Asthma Exacerbations in Adults.成人哮喘加重的预防和治疗。
J Allergy Clin Immunol Pract. 2021 Jul;9(7):2578-2586. doi: 10.1016/j.jaip.2021.05.016.
6
The comparison between children and adolescents with asthma provided by the real-world "ControL'Asma" study.真实世界的“控制哮喘”研究提供的哮喘儿童与青少年之间的比较。
J Asthma. 2022 Aug;59(8):1531-1536. doi: 10.1080/02770903.2021.1941089. Epub 2021 Jun 18.
7
Asthma in the Precision Medicine Era: Biologics and Probiotics.精准医学时代的哮喘：生物制剂和益生菌。
Int J Mol Sci. 2021 Apr 26;22(9):4528. doi: 10.3390/ijms22094528.
8
The real-world "ControL'Asma" study: a nationwide taskforce on asthma control in children and adolescents.真实世界“ControL'Asma”研究：全国范围内针对儿童和青少年哮喘控制的专项工作组。
Allergol Immunopathol (Madr). 2021 Jan 2;49(1):32-39. doi: 10.15586/aei.v49i1.14. eCollection 2021.
9
Role of Probiotics in Stimulating the Immune System in Viral Respiratory Tract Infections: A Narrative Review.益生菌在刺激病毒呼吸道感染中的免疫系统中的作用：叙述性综述。
Nutrients. 2020 Oct 16;12(10):3163. doi: 10.3390/nu12103163.
10
Prevention of Asthma: Targets for Intervention.预防哮喘：干预靶点。
Chest. 2020 Sep;158(3):913-922. doi: 10.1016/j.chest.2020.04.011. Epub 2020 Apr 21.

一项关于益生菌混合物对学龄儿童哮喘发作频率影响的分析。

A analysis on the effects of a probiotic mixture on asthma exacerbation frequency in schoolchildren.

作者信息

Drago Lorenzo, Cioffi Luigi, Giuliano Maria, Pane Marco, Ciprandi Giorgio

机构信息

Dept of Biomedical Sciences for Health, University of Milan, Milan, Italy.

Pediatric Primary Care ASL Napoli 2, Naples, Italy.

出版信息

ERJ Open Res. 2022 May 9;8(2). doi: 10.1183/23120541.00020-2022. eCollection 2022 Apr.

DOI:10.1183/23120541.00020-2022
PMID:35539434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9081543/
Abstract

https://bit.ly/382LYKV.

摘要

https://bit.ly/382LYKV. （此为网址，一般无需翻译，保留原样即可，若强行翻译为“https://比特链接/382LYKV”，不符合网址翻译规范且失去原有意义，故按要求保留）